Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Hydromorphone for Post-cesarean Pain
NCT01943565Phase 4Terminated
- Sponsor
- Brigham and Women's Hospital
- Start
- Dec 2014
- Primary completion
- Jul 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of hydromorphone in postoperative pain, sponsored by Brigham and Women's Hospital. Started Dec 2014; status: terminated.
02
Drugs
hydromorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT01943565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01943565.